SIGMA HEALTHCARE LIMITED (SIG)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
SIG - SIGMA HEALTHCARE LIMITED
FNArena Sector :
Health & Nutrition
Year End: January
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -3.13
Index: ASX300 | ALL-ORDS
FNArena Sector : Health & Nutrition
Year End: January
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -3.13
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.295
25 Apr |
0.000 OPEN $1.30 |
0.000 HIGH $1.30 |
0 LOW $1.30 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 50% |
OTHER COMPANIES IN THE SAME SECTOR | |||
CLV . EBO . EXL . MCP . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY23 Actual |
FY24 Actual |
FY25 Forecast |
FY26 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | N/A | 1.6 | xxx |
DPS (cps) | xxx | N/A | 1.0 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | 77.3 | xxx |
Dividend Yield | xxx | N/A | 0.8% | xxx |
Div Pay Ratio(%) | xxx | N/A | 60.1% | xxx |
Last ex-div: 28/03 - ex-div 0.5c (franking 50%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 0.4 |
DPS All | xxx | xxx | xxx | xxx | xxx | 1.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 3,322.1 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 55.4 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 42.0 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 0.14 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 0.67 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 0.53 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 0.35 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 0.67 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -8.40 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 27.3 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 10 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 127 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 137 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 89 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 356 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.87 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 4.7 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 0.14 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 3,132 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 262 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 14 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
SIG STOCK CHART
FNArena News on SIG
1 |
Weekly Ratings, Targets, Forecast Changes – 22-03-24Mar 25 2024 - Weekly Reports |
2 |
FNArena Corporate Results Monitor – 22-03-2024Mar 22 2024 - Australia |
3 |
Rudi’s View: Healthcare Under The ScannerMar 13 2024 - Rudi's View |
4 |
Weekly Ratings, Targets, Forecast Changes – 12-01-24Jan 15 2024 - Weekly Reports |
5 |
Weekly Ratings, Targets, Forecast Changes – 15-12-23Dec 18 2023 - Weekly Reports |
Latest Health & Nutrition News
1 |
Sigma Healthcare Promises Higher MarginsOct 03 2023 - Small Caps |
2 |
Sigma’s Win Not Neccessarily Ebos’ LossJun 14 2023 - Small Caps |
3 |
Sigma Healthcare: Brokers WaryMar 31 2022 - Australia |
4 |
Health & Wellness Boom On The ASXApr 29 2021 - Weekly Reports |
5 |
M&A Now On Sigma Healthcare’s AgendaMar 24 2021 - Australia |
6 |
McPherson’s Expands Into Herbal HealthNov 04 2020 - Small Caps |
7 |
Nine Ignored Companies Now Worth A LookSep 23 2020 - FYI |
8 |
Next Week At A Glance – 14-18 Sep 2020Sep 11 2020 - Weekly Reports |
9 |
Sigma Farewells API, Heralds New ContractDec 17 2019 - Australia |
10 |
Blackmores: Hopes Pinned On RestructuringNov 01 2019 - Australia |